(PharmaNewsWire.Com, July 28, 2020 ) Immunofluorescence assay is a powerful technique used to analyze the distribution of glycans, proteins, and small biological and non-biological molecules (cells and tissues) using antibodies conjugated with a fluorescent dye, known as fluorophore, which can be visualized using a fluorescence microscope or imaging systems.
The immunofluorescence assay market is expected to reach USD 2.01 Billion by 2023 from USD 1.43 Billion in 2017, at a CAGR of 5.8%.
The increasing prevalence of chronic diseases, increasing R&D spending, and increasing healthcare spending are the major factors driving the growth of the market. The base year considered for the study is 2017 and the forecast period includes 2018 to 2023.
On the basis of product, the reagents segment accounted for the largest share of the global market in 2017. The growing applications of biosciences and biotechnology within the pharmaceutical and healthcare fields, the rising prevalence of a number of diseases, growing R&D activities, and government initiatives to strengthen national research capabilities are the factors attributing for the largest share of the reagents segment.
The geographical regions mapped in the report are:
North America Europe Asia Pacific Rest of the World
Regional Growth, Development and Demand Analysis:
In 2017, North America accounted for the largest share of the market, followed by Europe and Asia Pacific. The rising incidence of chronic diseases, increasing R&D spending, increasing research activities, favorable government funding opportunities, and the presence of key players in this region are the major factors driving the growth of the immunofluorescence assay market in North America.
Objectives of the Study:
To define, describe, and forecast the global immunofluorescence assay market on the basis of product, type, disease, end user, and region To provide detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and challenges) To strategically analyze micromarkets with respect to the individual growth trends, future prospects, and contributions to the overall market To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World, along with major countries in these regions To profile the key players and comprehensively analyze their market shares and core competencies in the market To track and analyze competitive developments such as product launches, expansions, agreements, partnerships, acquisitions and research and development activities in the global market
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
